What's Happening?
KORU Medical Systems presented real-world data on its FreedomEDGE Syringe Infusion System at the 51st Annual Oncology Nursing Society Congress. The study evaluated the system's impact on nursing workflow, nurse experience, and patient-reported outcomes
across four U.S. community infusion centers. The findings highlighted the system's efficiency, with 100% of doses administered successfully and reduced ergonomic strain for nurses. Both nurses and patients reported high satisfaction levels, and nurses were able to multitask during 80% of pump infusions. The FreedomEDGE system supports large-volume subcutaneous drug delivery and is approved in over 30 countries.
Why It's Important?
The presentation of KORU Medical's FreedomEDGE system at a major oncology congress underscores its potential to improve healthcare delivery in infusion clinics. By reducing nurse strain and increasing efficiency, the system can enhance the quality of care and patient satisfaction. This innovation is particularly relevant as healthcare systems seek to optimize resources and improve patient outcomes. The high adherence rate and patient satisfaction suggest that the system could become a standard in subcutaneous drug administration, potentially influencing practices in oncology and other medical fields.
What's Next?
Following the positive reception at the Oncology Nursing Society Congress, KORU Medical may pursue further studies to expand the use of the FreedomEDGE system in other medical settings. The company might also explore partnerships with biopharmaceutical companies to integrate the system into clinical trials and drug development processes. As the system gains traction, it could lead to broader adoption in healthcare facilities, driving demand for training and support services. Regulatory approvals in additional countries could also be pursued to expand the system's global reach.
